COMMONWEALTH EQUITY SERVICES, LLC - XERIS PHARMACEUTICALS INC ownership

XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 72 filers reported holding XERIS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.40 and the average weighting 0.0%.

Quarter-by-quarter ownership
COMMONWEALTH EQUITY SERVICES, LLC ownership history of XERIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$239,000
-41.6%
97,584
-3.0%
0.00%0.0%
Q2 2021$409,000
-6.6%
100,584
+3.4%
0.00%0.0%
Q1 2021$438,000
-6.4%
97,234
+2.1%
0.00%0.0%
Q4 2020$468,000
-16.1%
95,234
+1.1%
0.00%
-50.0%
Q3 2020$558,000
+128.7%
94,234
+2.5%
0.00%
+100.0%
Q2 2020$244,000
+1184.2%
91,934
+819.3%
0.00%
Q1 2020$19,00010,0000.00%
Other shareholders
XERIS PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Redmile Group, LLC 3,000,641$29,496,0000.99%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,308,666$22,694,0000.92%
ArrowMark Colorado Holdings LLC 1,656,422$16,283,0000.16%
IHT Wealth Management, LLC 57,028$561,0000.08%
MOORE CAPITAL MANAGEMENT, LP 50,000$492,0000.02%
Engineers Gate Manager LP 20,264$199,0000.01%
FEDERATED HERMES, INC. 300,000$2,949,0000.01%
FMR LLC 4,048,102$39,793,0000.01%
Invesco Ltd. 1,000,000$9,830,0000.00%
MetLife Investment Management, LLC 14,041$138,0230.00%
View complete list of XERIS PHARMACEUTICALS INC shareholders